Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Nov;6(4):194-200.
doi: 10.1007/s11904-009-0026-8.

Pediatric adherence to HIV antiretroviral therapy

Jessica Haberer  1 , Claude Mellins
Affiliations
Review

Pediatric adherence to HIV antiretroviral therapy

Jessica Haberer et al. Curr HIV/AIDS Rep. 2009 Nov.

Abstract

More than 2 million children are infected with HIV globally. Pediatric antiretroviral therapy (ART) adherence is complex, and current levels are often suboptimal. As established treatment programs in developed settings struggle with chronic therapy and nascent treatment programs in resource-limited settings expand, the importance and challenges of good adherence to ART are becoming ever more clear. Adherence behavior is influenced by many factors, which may be categorized as characteristics of the child, the caregiver(s) and family, the regimen, and society and culture. Many of these influences complicate measurement of pediatric adherence, and there is no gold standard. This article provides a conceptual framework and evidence-based look at the factors influencing ART adherence in children and aims to identify areas for intervention for this vulnerable population in need.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Factors contributing to pediatric adherence
See this image and copyright information in PMC

References

    1. Joint United Nations Program (UNAIDS) 2008 Report on the global AIDS epidemic; UNAIDS: Geneva. [July 2009]. Available at: http://www.unaids.org/en/Knowledge Centre/HIVData/ GlobalReport/2008/200....
    1. Burns DN, Mofenson LM. Paediatric HIV-1 infection. Lancet. 1999;354(S2):1–6. - PubMed
    1. Wiznia A, Stanley K, Krogstad P, et al. Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team. AIDS Res Hum Retroviruses. 2000;16:1113–1121. - PubMed
    1. Havens JF, Mellins CA. Psychiatric Aspects of HIV/AIDS. In: Rutter M, Bishop D, Pine D, Scott S, Stevenson J, Taylor E, Thapar A, editors. Rutter's Child and Adolescet Psychiatry. 5th ed. Blackwell Publishing; Oxford: 2008. pp. 945–955.
    1. Yogev R. Balancing the upside and downside of antiretroviral therapy in children. JAMA. 2005 May 11;293(18):2272–4. - PubMed

Publication types

Substances